Alaunos Therapeutics Income Statement (2011-2025) | TCRT

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Mar2011	Jun2011	Sep2011	Dec2011	Mar2012	Jun2012	Sep2012	Dec2012	Mar2013	Jun2013	Sep2013	Dec2013	Mar2014	Jun2014	Sep2014	Dec2014	Mar2015	Jun2015	Sep2015	Dec2015	Mar2016	Jun2016	Sep2016	Dec2016	Mar2017	Jun2017	Sep2017	Dec2017	Mar2018	Jun2018	Sep2018	Dec2018	Mar2019	Jun2019	Sep2019	Mar2020	Jun2020	Sep2020	Dec2020	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025
Revenue & cost
Revenue	0.07M	0.20M	0.20M	0.20M	0.20M	0.20M	0.20M	0.20M	0.20M	0.20M	0.20M	0.20M	0.20M	0.20M	0.63M	0.34M	0.27M	0.27M	1.87M	1.92M	1.97M	1.70M	1.60M	1.60M	1.60M	1.60M	1.60M	1.60M	0.15M													0.40M	0.00M			2.91M	0.01M		0.00M		0.00M	0.00M	0.00M		0.00M	0.00M
Cost of Revenue		9.12M	10.67M			161.15M
Gross Profit		-8.93M	-10.47M			-160.95M
Operating items
Research & Development	24.64M	9.12M	10.67M	128.90M	13.98M	18.26M	16.21M	212.34M	19.11M	14.78M	6.25M	255.20M	6.54M	8.35M	9.73M		74.25M	7.42M	10.00M	8.14M	10.20M	129.23M	8.97M	9.39M	11.97M	10.83M	11.11M	11.18M	10.18M	7.49M	8.26M	8.20M		10.00M	8.64M				24.58M		13.57M	14.52M	8.22M	5.58M	5.94M	7.89M	5.61M	6.50M	5.19M	3.66M	0.93M	0.13M	0.18M	0.14M	-0.09M	0.35M	0.18M	0.47M
Selling, General & Administrative	3.35M	3.92M	3.74M	68.80M	4.85M	4.90M	5.71M	88.32M	4.67M	3.72M	3.07M	103.98M	3.44M	3.03M	2.84M		4.25M	7.07M	3.06M	3.26M	3.81M	3.71M	3.54M	3.32M	3.60M	3.78M	3.57M	3.85M	6.16M	4.89M	4.31M	4.56M		4.75M	4.81M				13.96M		9.07M	8.17M	2.10M	3.50M	3.43M	3.28M	2.92M	3.17M	3.04M	3.58M	2.43M	1.62M	0.99M	1.01M	0.84M	0.75M	0.85M	0.72M
Restructuring Costs																																																		0.42M	0.85M
Other Operating Expenses				-181.08M				-261.62M				-352.26M				10.94M			6.97M																	18.66M	18.61M	20.32M	-15.77M				0.74M		-0.13M				-0.24M	1.01M	3.74M
Operating Expenses	27.99M	13.05M	14.41M	16.62M	18.83M	23.17M	21.93M	39.04M	23.78M	18.50M	9.31M	6.92M	9.98M	11.38M	12.57M	10.94M	78.50M	14.50M	20.04M	11.40M	14.01M	132.94M	12.51M	12.71M	15.56M	14.61M	14.68M	15.03M	16.34M	12.38M	12.57M	12.76M		14.75M	13.45M	18.66M	18.61M	20.32M	22.77M		22.64M	22.69M	11.05M	9.09M	9.23M	11.18M	8.53M	9.67M	7.99M	8.66M	7.95M	1.74M	1.17M	1.15M	0.76M	1.09M	1.04M	1.19M
Operating Income	-27.93M	-12.85M	-14.21M	-16.42M	-18.63M	-22.97M	-21.73M	-38.84M	-23.58M	-18.30M	-9.12M	-6.72M	-9.78M	-11.18M	-11.94M	-10.60M	-78.23M	-14.22M	-18.17M	-9.48M	-12.04M	-131.24M	-10.91M	-11.11M	-13.96M	-13.01M	-13.08M	-13.44M	-16.20M	-12.38M	-12.57M	-12.76M		-14.75M	-13.45M	-18.66M	-18.61M	-20.32M	-22.77M		-22.64M	-22.30M	-11.05M	-9.09M	-9.23M	-8.26M	-8.52M	-9.67M	-7.98M	-8.66M	-7.95M	-1.74M	-1.17M	-1.15M	-0.76M	-1.09M	-1.04M	-1.19M
EBIT	-27.93M	-12.85M	-14.21M	-16.42M	-18.63M	-22.97M	-21.73M	-38.84M	-23.58M	-18.30M	-9.12M	-6.72M	-9.78M	-11.18M	-11.94M	-10.60M	-78.23M	-14.22M	-18.17M	-9.48M	-12.04M	-131.24M	-10.91M	-11.11M	-13.96M	-13.01M	-13.08M	-13.44M	-16.20M	-12.38M	-12.57M	-12.76M		-14.75M	-13.45M	-18.66M	-18.61M	-20.32M	-22.77M		-22.64M	-22.30M	-11.05M	-9.09M	-9.23M	-8.26M	-8.52M	-9.67M	-7.98M	-8.66M	-7.95M	-1.74M	-1.17M	-1.15M	-0.76M	-1.09M	-1.04M	-1.19M
Non-operating items
Other Non Operating Income	13.94M	2.12M	13.39M	3.16M	-5.81M	1.74M	3.94M	8.57M	10.79M	-0.40M	-7.41M	-1.79M	0.08M	5.60M	5.85M	0.19M	-0.00M	0.01M	-0.00M	0.01M	0.02M	0.04M	0.04M	-3.53M	-1.56M	0.09M	0.20M	-0.00M	0.15M	0.18M	-0.17M	0.17M		0.13M	0.20M				-0.14M			0.01M	0.00M	-0.02M	0.04M	0.25M	0.25M	0.48M	0.28M	0.19M	0.11M	0.06M	0.04M	0.02M	0.01M	0.02M	0.02M	0.03M
Non Operating Income	-0.00M	0.01M	0.02M	4.71M	-0.03M	0.00M	-0.04M	4.70M	-0.00M	0.01M	-0.19M	4.12M	-0.01M	0.00M	0.00M		-0.00M	0.01M	-0.00M	0.01M	0.02M	0.04M	0.04M	0.03M	0.04M	0.09M	0.17M	0.17M	0.15M	0.16M	0.15M	0.17M		0.13M	0.20M				-0.14M		-0.03M	-0.44M	-0.74M	-0.70M	-0.70M	-0.59M	-0.64M	0.48M	-0.79M	0.19M	2.03M	0.06M	0.04M	0.02M	0.01M	0.02M	0.02M	0.03M
Net income details
EBT	-27.93M	-12.85M	-14.21M	-16.42M	-18.63M	-22.97M	-21.73M	-38.84M	-23.58M	-18.30M	-9.12M	-6.72M	-9.78M	-11.18M	-11.94M	-10.60M	-78.23M	-14.22M	-18.17M	-9.48M	-12.04M	-131.24M	-10.91M	-11.11M	-13.96M	-13.01M	-13.08M	-13.44M	-16.20M	-12.38M	-12.57M	-12.76M		-14.75M	-13.45M	-18.66M	-18.61M	-20.32M	-22.77M		-22.64M	-22.74M	-11.81M	-9.79M	-9.97M	-9.11M	-9.42M	-10.57M	-9.05M	-8.66M	-7.95M	-1.74M	-1.17M	-1.15M	-0.76M	-1.09M	-1.04M	-1.19M
Profit After Tax	-39.01M	-10.72M	-0.80M	-13.24M	-24.47M	-23.61M	-17.82M	-30.23M	-12.80M	-18.69M	-16.71M	-8.90M	-9.71M	-5.58M	-6.09M	-10.40M	-78.23M	-14.21M	-18.17M	-9.48M	-12.02M	-131.20M	-14.45M	-14.76M	-19.66M	-17.73M	-17.60M	-18.27M	-21.14M	-12.03M	-12.59M	194.54M		-14.62M	-74.00M	-18.29M	-18.60M	-20.32M	-22.77M		-22.67M	-22.73M	-11.79M	-9.79M	-9.93M	-8.85M	-9.16M	-10.05M	-8.77M	-8.48M	-7.84M	-1.68M	-1.13M	-1.13M	-0.74M	-1.07M	-1.05M	-1.16M
Income from Continuing Operations	-27.93M	-12.85M	-14.21M	-16.42M	-18.63M	-22.97M	-21.73M	-38.84M	-23.58M	-18.30M	-9.12M	-6.72M	-9.78M	-11.18M	-11.94M	-10.60M	-78.23M	-14.22M	-18.17M	-9.48M	-12.04M	-131.24M	-10.91M	-11.11M	-13.96M	-13.01M	-13.08M	-13.44M	-16.20M	-12.38M	-12.57M	-12.76M		-14.75M	-13.45M	-18.66M	-18.61M	-20.32M	-22.77M		-22.64M	-22.74M	-11.81M	-9.79M	-9.97M	-9.11M	-9.42M	-10.57M	-9.05M	-8.66M	-7.95M	-1.74M	-1.17M	-1.15M	-0.76M	-1.09M	-1.04M	-1.19M
Consolidated Net Income	-27.93M	-12.85M	-14.21M	-16.42M	-18.63M	-22.97M	-21.73M	-38.84M	-23.58M	-18.30M	-9.12M	-6.72M	-9.78M	-11.18M	-11.94M	-10.60M	-78.23M	-14.22M	-18.17M	-9.48M	-12.04M	-131.24M	-10.91M	-11.11M	-13.96M	-13.01M	-13.08M	-13.44M	-16.20M	-12.38M	-12.57M	-12.76M		-14.75M	-13.45M	-18.66M	-18.61M	-20.32M	-22.77M		-22.64M	-22.74M	-11.81M	-9.79M	-9.97M	-9.11M	-9.42M	-10.57M	-9.05M	-8.66M	-7.95M	-1.74M	-1.17M	-1.15M	-0.76M	-1.09M	-1.04M	-1.19M
Income towards Parent Company	-27.93M	-12.85M	-14.21M	-16.42M	-18.63M	-22.97M	-21.73M	-38.84M	-23.58M	-18.30M	-9.12M	-6.72M	-9.78M	-11.18M	-11.94M	-10.60M	-78.23M	-14.22M	-18.17M	-9.48M	-12.04M	-131.24M	-10.91M	-11.11M	-13.96M	-13.01M	-13.08M	-13.44M	-16.20M	-12.38M	-12.57M	-12.76M		-14.75M	-13.45M	-18.66M	-18.61M	-20.32M	-22.77M		-22.64M	-22.74M	-11.81M	-9.79M	-9.97M	-9.11M	-9.42M	-10.57M	-9.05M	-8.66M	-7.95M	-1.74M	-1.17M	-1.15M	-0.76M	-1.09M	-1.04M	-1.19M
Preferred Dividend Payments																							3.59M	3.53M	4.17M	4.87M	4.90M	5.00M	5.12M	5.46M	6.07M	0.34M
Net Income towards Common Stockholders	-27.93M	-12.85M	-14.21M	-16.42M	-18.63M	-22.97M	-21.73M	-38.84M	-23.58M	-18.30M	-9.12M	-6.72M	-9.78M	-11.18M	-11.94M	-10.60M	-78.23M	-14.22M	-18.17M	-9.48M	-12.02M	-131.20M	-14.45M	-14.76M	-19.66M	-17.73M	-17.60M	-18.27M	-21.14M	-17.49M	-18.66M	194.54M		-14.62M	-74.00M	-18.66M	-18.61M	-20.32M	22.07M		-22.67M	-22.74M	-11.81M	-9.79M	-9.93M	-9.11M	-9.42M	-10.57M	-9.05M	-8.66M	-7.95M	-1.74M	-1.17M	-1.15M	-0.76M	-1.09M	-1.04M	-1.19M
Additional items
EPS (Basic)	-0.65	-0.16	-0.01	-0.25	-0.32	-0.30	-0.23	-0.49	-0.15	-0.22	-0.20	-0.08	-0.10	-0.06	-0.06	-0.10	-0.69	-0.11	-0.14	-0.08	-0.09	-1.01	-0.11	-0.11	-0.15	-0.13	-0.13	-0.13	-0.15	-0.12	-0.13	1.36		-0.09	-0.43	-0.09	-0.09	-0.10	0.11		-0.11	-0.11	-0.06	-0.05	-0.05	-0.04	-2.48	-0.63	-5.49	-5.30	-4.90	-1.05	-0.71	-0.70	-0.47	-0.67	-0.63	-0.55
EPS (Weighted Average and Diluted)		-0.19	-0.21			-0.29	-0.28																	-0.11				-0.13	-0.15	-0.12	-0.13	1.35				-0.09	-0.09	-0.10	0.11		-0.11	-0.11	-0.06	-0.05	-0.05	-0.04	-2.48	-0.63	-5.49	-5.30	-4.90	-1.05	-0.71	-0.70	-0.47	-0.67	-0.63	-0.55
Shares Outstanding (Weighted Average)	60.41M	67.23M	68.10M	66.00M	75.62M	78.51M	78.67M	78.55M	82.91M	83.08M	83.16M	85.94M	100.23M	100.42M	100.43M	101.13M	113.41M	128.41M	129.73M	125.42M	130.16M	130.39M	130.50M	130.39M	130.70M	135.63M	140.63M	136.94M	140.85M	141.02M	141.19M	143.51M	160.64M	160.79M	170.61M	199.81M	212.79M	212.84M	209.64M	213.95M	214.43M	214.54M	214.40M	214.95M	215.00M	215.10M	14.48M	15.98M	1.60M	1.60M	1.60M	1.60M	1.60M	1.60M	1.60M	1.60M	1.68M	2.18M
Shares Outstanding (Diluted Average)		67.23M	68.10M			78.51M	78.67M																	130.39M				136.94M				143.71M							209.64M		214.43M	214.54M	214.40M	214.95M	215.00M	215.10M	14.48M	15.98M	1.60M	1.60M	1.60M	1.60M	1.60M	1.60M	1.60M	1.60M	1.68M	2.18M
EBITDA	-27.93M	-12.85M	-14.21M	-16.42M	-18.63M	-22.97M	-21.73M	-38.84M	-23.58M	-18.30M	-9.12M	-6.72M	-9.78M	-11.18M	-11.94M	-10.60M	-78.23M	-14.22M	-18.17M	-9.48M	-12.04M	-131.24M	-10.91M	-11.11M	-13.96M	-13.01M	-13.08M	-13.44M	-16.20M	-12.38M	-12.57M	-12.76M		-14.75M	-13.45M	-18.66M	-18.61M	-20.32M	-22.77M		-22.64M	-22.30M	-11.05M	-9.09M	-9.23M	-8.26M	-8.52M	-9.67M	-7.98M	-8.66M	-7.95M	-1.74M	-1.17M	-1.15M	-0.76M	-1.09M	-1.04M	-1.19M
Interest Expenses																																										0.44M	0.76M	0.70M	0.74M	0.84M	0.90M	0.90M	1.07M

Research Tools

Alaunos Therapeutics Income Statement (2011-2025) | TCRT

Create an account

Sign In

Reset Password